Oracle has agreed to acquire Convergin Inc., a Herzliya, Israel-based provider of real-time service brokering solutions. No financial terms were disclosed. Convergin has raised around $10 million in VC funding from Pitango Venture Capital and Rich Investment Ltd.
1 min read · 12 February 2010
1 min read · 12 February 2010
2 min read · 11 February 2010
2 min read · 11 February 2010
CaliSolar Inc., a Sunnyvale, Calif.-based developer of solar cells using “dirty” metallurgical grade silicon, has acquired 6N Silicon Inc., an Ontario-based supplier of solar-grade silicon to the photovoltaic industry. No financial terms were disclosed, except that CaliSolar has raised $22.5 million in new funding from existing shareholders and 6N Silicon backers. CaliSolar previously raised over $100 million from Hudson Clean Energy, Advanced Technology Ventures and Globespan Capital Partners. 6N Silicon had raised more than $20 million from Good Energies, Ventures West Management and Yaletown Venture Partners.
3 min read · 11 February 2010
Dell has agreed to acquire KACE Networks Inc., a Mountain View, Calif.-based systems management appliance company focused on mid-sized businesses and public institutions. No financial terms were disclosed. KACE has raised over $11 million in VC funding, from Norwest Venture Partners, Focus Ventures and Sigma Partners.
2 min read · 11 February 2010
Zenverge Inc., a Cupertino, Calif.-based developer of advanced media integrated circuits, has raised an undisclosed amount of new VC funding. Return backers include DCM, Motorola Ventures and Norwest Venture Partners.
2 min read · 11 February 2010
RadPharm Inc., a Princeton, N.J.-based provider of medical image review services for clinical research, has merged with Medifacts International Inc., a Rockville, Md.-based cardiovascular core lab. The combined company will be based in Princeton, and be called CoreLab Partners. RadPharm has raised around $32 million in VC funding from SiemensVenture Capital, Ampersand Ventures, Adams Street Partners and Tang Capital Management. Medifacts has raised around $22 million from Ampersand Ventures and SV Life Sciences.
3 min read · 11 February 2010
Somnus Therapeutics Inc., a Bedminster, N.J.-based developer of a delayed-release sleep-maintenance therapy, has raised $15 million in Series A funding. CTI Life Sciences Fund led the round, and was joined by seed backer Care Capital.
2 min read · 11 February 2010
1 min read · 11 February 2010
